Launched as a joint venture between Sanofi, Capgemini, Generali and Orange - it aims to stimulate the development of e-health solutions.
It is the first and only non-proprietary accelerator for startups that wish to improve their ability to engage with pharma as clients and partners.
The top two peer-selected startups will be eligible to receive up to a total of $200,000 in grant funding.
During the quarter, the average deal size ballooned to $45.9M (up from $31.7M in 2020), and SPACs continued to offer a new path to liquidity.
The focus is on fostering development of integrated healthcare solutions in fields of cardiometabolic and renal diseases, oncology, and women's health.
Initially, the company is taking a telemedicine approach, but eventually plans to open physical locations.
With 24 mega-deals so far, 2020 will be the largest funding year ever for digital health...
It brings 2020's year-to-date funding total to around $16B, more than any previous full year on record.
Beginning in January, the healthtech startups will have access to partners, a tailored curriculum and co-working space.
The selected companies will be supported by Bayer's G4ADigital Health Partnerships program to drive forward innovative solutions for patients.